EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

The association between proton pump inhibitor use and the risk of mortality in patients with kidney disease: a systematic review and meta-analysis

Ilsoo Park, Hyun Jin Song, Hyun-Ju Seo

European Journal of Clinical Pharmacology · 2026-04 · 82 (4)

DOI: 10.1007/s00228-026-04022-w ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 07.03.2026. Verfasst von Ilsoo Park und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Health and Science, Eastern University, St. Davids, PA, USA. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Kidney Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Use of proton pump inhibitor (PPI) has been associated with adverse health outcomes, including increased risk of all-cause mortality. Evidence suggests that individuals with kidney disease who use PPIs may experience higher mortality, though the nature of this association is not well established. OBJECTIVE: To assess the relationship between PPI use and mortality among individuals with kidney disease through a systematic review and meta-analysis. METHODS: A comprehensive search of Ovid-MEDLINE, Ovid-EMBASE, and Cochrane CENTRAL was conducted through April 2025 to identify randomized controlled trials and observational studies examining mortality among PPI users versus non-users with kidney disease. Both unadjusted mortality rates and adjusted hazard ratios (aHRs) were extracted. A random-effects meta-analysis was performed using the Hartung-Knapp-Sidik-Jonkman method, with the Sidik-Jonkman estimator used for between-study variance (τ2). Study heterogeneity was evaluated using the I2 statistic and Cochran's Q test. Subgroup analyses were carried out based on follow-up length, population characteristics, geographic region, and risk of bias level. RESULTS: The review included 24 observational studies encompassing 216,032 individuals with kidney disease. Across 20 cohorts from 17 observational studies, mortality was 23.2% among PPI users and 22.1% among non-users. Pooled adjusted estimates from 18 studies (20 cohorts) indicated a significantly increased risk of death in PPI users (aHR 1.26; 95% CI, 1.11-1.42). Considerable heterogeneity was observed, but subgroup analyses revealed consistent trends. CONCLUSIONS: Our meta-analysis showed that PPI use was linked to elevated mortality risk in kidney disease populations. Careful consideration is advised when prescribing PPIs, and further research is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsKidney DiseasesHumans

Stichwörter der Autor:innen

Proton pump inhibitors ∙ mortality ∙ elderly ∙ systematic review ∙ meta-analysis

Substanzen

Proton Pump Inhibitors

Autor:innen und Institutionen

  • College of Health and Science, Eastern University, St. Davids, PA, USA.
  • College of Pharmacy, University of Florida, Gainesville, FL, USA.
  • College of Nursing, Chungnam National University, 266 Munhwa-Ro, Jung-Gu, Daejeon, 35015, South Korea. hjseo20@cnu.ac.kr.

Zitieren

APA

Park, I., Song, H. J., & Seo, H. J. (2026). The association between proton pump inhibitor use and the risk of mortality in patients with kidney disease: a systematic review and meta-analysis. European Journal of Clinical Pharmacology, 82(4). https://doi.org/10.1007/s00228-026-04022-w

Vancouver

Park I, Song HJ, Seo HJ. The association between proton pump inhibitor use and the risk of mortality in patients with kidney disease: a systematic review and meta-analysis. European Journal of Clinical Pharmacology. 2026;82(4). doi:10.1007/s00228-026-04022-w

BibTeX
@article{Park2026,
  author = {Park, Ilsoo and Song, Hyun Jin and Seo, Hyun-Ju},
  title = {The association between proton pump inhibitor use and the risk of mortality in patients with kidney disease: a systematic review and meta-analysis},
  journal = {European Journal of Clinical Pharmacology},
  year = {2026},
  volume = {82},
  number = {4},
  doi = {10.1007/s00228-026-04022-w}
}
Kostenlos starten →